AstraZeneca PLC - Total Revenue

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Revenue" stands at 58.16 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

AstraZeneca PLC's third quarter result of 15.19 Billion USD for the item "Total Revenue" represents an increase of 2.34 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 15.19 Billion USD for the item "Total Revenue" represents an increase of 8.78 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of 58.16 Billion USD for the item "Total Revenue" represents an increase of 2.15 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.40 percent compared to the value the year prior.
The 1 year change in percent is 12.40.
The 3 year change in percent is 32.10.
The 5 year change in percent is 118.62.
The 10 year change in percent is 132.71.

The Serie's long term average value is 32.24 Billion United States Dollars. It's latest available value, on 09/30/2025, is 80.38 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2017, to it's latest available value, on 09/30/2025, is +167.97%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.